Described herein are pharmaceutical packaging units which prevent oxidative degradation of morphine, hydromorphone, promethazine and various oxygen-sensitive drugs, these types of programs including a syringe using an oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister packaging with quite small permeability to oxygen and